Detalhe da pesquisa
1.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
2.
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood.
Immunother Adv
; 3(1): ltad001, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818683
3.
A Multicentre Retrospective Analysis of Toxicity in 6-weekly Versus 3-weekly Pembrolizumab.
J Immunother
; 44(4): 175-178, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492031
4.
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Lung Cancer
; 113: 115-120, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29110837
5.
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients.
Melanoma Res
; 25(5): 432-42, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26225580